Purpose. Multiple Helicobacter pylori strains colonize and coexist in the stomach of one single patient, carrying heterogeneous distributions of cag genotypes. The oesophagus provides a niche for H. pylori colonization; however, little is known about its adaptive role.
INTRODUCTION
Helicobacter pylori is a Gram-negative, flagellated, microaerophilic bacterium that selectively colonizes the gastric mucosa, commonly giving rise to peptic ulceration, gastric lymphoma and gastric adenocarcinoma [1] . Around 70 % of strains possess the cytotoxin-associated gene A (cagA), this being the principal marker of the so-called cag pathogenicity island (PAI), the presence of which has been associated with the development of gastric cancer [2] . Among cag-PAI genes, the most studied is cagA that encodes for the CagA protein. CagA is an oncoprotein, which is delivered into gastric epithelial cells via a bacterial type IV secretion system. It can induce adhesion, proliferation, morphological alterations, pro-inflammatory interleukin secretion and apoptosis, which result from multiple transformations in the host signalling pathways [2, 3] . The gene cagE encodes a protein responsible for the induction of interleukin 8 (IL-8), eliciting a mucosal inflammatory response and epithelial cell damage. The gene virB11 encodes a functional adenosine triphosphatase activity and, together with other cag-PAI genes, constitutes the core structure for the type IV secretion system that allows the delivery of CagA protein into gastric cells [4] . Additionally, cagE and virB11 have been studied as markers of cag-PAI, and their presence is related to severe gastroduodenal diseases, such as ulcer and gastric cancer, rather than to gastritis [5] .
H. pylori exhibits a rather high genetic diversity, greater than most bacteria, with exceptionally high rates of DNA point mutations as well as intra-and inter-genetic recombination, which allow its adaptation to changing environments [6] . The most significant consequences of these genomic changes are antibiotic resistance and differences in the prevalence or expression of bacterial virulence factors [7] . Antibacterial resistance is the major cause for treatment failure in first eradication regimes. At present, the first line therapy, recommended by the Maastricht consensus report, contemplates the use of a proton pump inhibitor and the antibiotics amoxicillin and clarithromycin or metronidazole. This scheme has been generally adopted worldwide [8] .
Studies in developed countries show that most strains of H. pylori isolated from different sites in the stomach of individual hosts carry homogeneous DNA profiles [9] , different from multiple-strain infections reported in developing countries such as China, India, Mexico and Brazil [9] [10] [11] [12] . In Venezuela, a high frequency of gastric H. pylori colonization with multiple strains has been demonstrated [13] ; however, few studies deal with the oesophageal colonization of H. pylori [14] [15] [16] . The oesophagus is a potential environment for bacterial colonization: alterations of the microenvironment, such as refluxrelated diseases, oesophagitis, Barrett's oesophagus or oesophageal carcinoma, could affect the bacterial biota and the oesophageal epithelium [17] . The role of H. pylori infection in these diseases is controversial; however, H. pylori can survive for a certain amount of time in gastric juice in the oesophagus [18] . Recent studies carried out by our group in Venezuelan dyspeptic patients have shown a high frequency of H. pylori infection (53-86 %) and heterogeneity of cag genotypes in biopsies of the gastroesophageal mucosa [15, 19] . However, the oesophageal colonization by multiple strains of H. pylori has not yet been reported.
In order to establish if the oesophageal H. pylori colonization results from circulating strains in the stomach, we determined cag-PAI genotypes associated with H. pylori virulence as well as antimicrobial susceptibility profiles of isolates obtained from the gastroesophageal mucosa. Furthermore, we also investigated if the H. pylori colonization in oesophagus is related to an inflammatory response through IL-8 expression induced by CagA.
METHODS

Sample collection and bacterial culture
Patients consulting the Gastroenterology Unit of the Oncology Service of the Hospital del Instituto Venezolano de los Seguros Sociales with gastrointestinal symptoms of dyspepsia (upper abdominal pain, heartburn and reflux), requiring upper-gastrointestinal endoscopy, were recruited into this study. All volunteers signed an informed consent form and the bioethics committees of Instituto Venezolano de Investigaciones Científicas and Hospital del Instituto Venezolano de los Seguros Sociales approved this study. Previous data of H. pylori DNA in biopsies from both mucosae (80 patients) were used to obtain H. pylori cultures [19] . Only eight subjects (two male and six female), aged 30-60 years (mean age, 44 years), matching H. pylori-positive cultures in both mucosae were selected. Endoscopic observation on these eight patients indicated that one (12.5 %) had gastric ulcer, two (25 %) had antral gastritis, one (12.5 %) had only gastritis, four (50 %) had hiatal hernia and four (50 %) had apparently normal gastric mucosa. All patients presented apparently normal oesophageal mucosa. During the endoscopy procedure, three antral and three oesophageal biopsy specimens were collected from each patient as previously described [19] . One biopsy specimen from each mucosa was immediately placed in formalin for histopathology and immunofluorescence studies; the other two biopsies were submitted for H. pylori culture.
Gastroesophageal biopsies of eight dyspeptic patients (positive for H. pylori infection) were homogenized with 300 µl PBS solution (0.9 %) in 1.5 ml tubes and shaken for 50 s at 5000 r.p.m. in a mini-beadbeater-1 (BioSpec Products). A 100 µl volume of each suspension was seeded (duplicate) on chocolate agar selective medium (blood agar base plates, Difco), supplemented with 10 % (v/v) sheep blood and a mixture of antibiotics and fungicide: vancomycin (10 µg ml ) and amphotericin B (2.5 µg ml -1 ) (Sigma-Aldrich). The plates were incubated at 37 C in microaerophilic atmosphere (Becton Dickinson) for 4-7 days. Small translucent colonies of H. pylori were identified by morphological characteristics, Gram staining and rapid urease test (Ure-IVIC; [20] ). For each positive culture of H. pylori, six single colonies were picked for further culturing, and the remaining colonies were pooled and preserved in Brucella broth plus 15 % (w/v) glycerol at À80 C. The colonies of H. pylori selected were sub-cultured and preserved under the same conditions as described before. A total of 96 isolates (six single colonies obtained from each mucosa per patient) were processed separately for antimicrobial susceptibility testing and DNA extraction. The DNA from 96 H. pylori isolates was extracted using the QIAamp DNA Mini Kit (Qiagen) following the manufacturer's instructions and stored at À20 C.
Antibiotic susceptibility test
Five antibiotics against H. pylori were tested: clarithromycin, amoxicillin, levofloxacin, tetracycline and metronidazole, through the epsilometer method (Etest, bioMerieux). The antibiotic concentrations ranged from 0.0016 to 256 mg l -1 for clarithromycin, amoxicillin, tetracycline and metronidazole and from 0.002 to 32 mg l -1 for levofloxacin. Antibiotic Etest strips were applied individually to five chocolate agar plates, which were inoculated for each isolate. Additionally, one plate was used as growth control without antibiotic. A total of 576 plates were incubated at 37 C in microaerophilic atmosphere (Becton Dickinson) for 4-7 days. An elliptical zone of inhibition is produced, corresponding to the MIC. The results were read according to the supplier's recommendations. The resistance breakpoints at which we considered there was growth inhibition of the micro-organism in accordance with the Clinical and Laboratory Standards Institute [21] were as follows: MIC 1 mg l -1 for clarithromycin, MIC 0.5 mg l -1
for amoxicillin, MIC 2 mg l -1 for tetracycline, MIC 1 mg l -1 for levofloxacin and MIC 8 mg l -1 for metronidazole as previously described [22] . A strain of H. pylori ATCC 43504 was used as a control strain for antimicrobial susceptibility testing.
Helicobacter genus and H. pylori species PCR assays Helicobacter spp. and H. pylori infection were detected by PCR using genus-and species-specific primers for 16S rRNA, glmM and ureA genes [23] [24] [25] . PCRs were performed in a thermal cycler GeneAmp PCR System 9700 (Applied Biosystems) using Colorless Go Taq Hot Start Master Mix (Promega), using the same cycling conditions as originally described for each pair of primers (Table 1) . Each reaction contained all components of the PCR, 2-4 µl extracted DNA, 3 µl primer mix (5 µM) and sterile distilled water to a final volume of 25 µl. Two positive controls were used as templates for each PCR assay: (a) DNA from H. pylori isolated from a Venezuelan patient with gastritis and (b) DNA from H. pylori reference strain 26695 [26] . Subsequently, the amplicons were visualized by running the reaction mixture in a TBE agarose gel [2 % (w/v)], stained with ethidium bromide and observed under a UV transilluminator.
cag-PAI genotypes
The cagA, cagE and virB11 presence was investigated in 96 isolates for the detection of genotypes associated with H. pylori cag-PAI in both mucosae, using specific primers described for each gene, as shown in Table 1 [4, 27] . PCRs were performed using Colorless Go Taq Hot Start Master Mix (Promega), as described above. According to the genetic composition of the cag-PAI, we considered a complete cag-PAI when all three genes were present, a partial cag-PAI when at least one gene was lacking and a deleted island when all three genes were absent.
Histopathology
Formalin-fixed biopsies were embedded in paraffin. Sections of 4 µm were cut and placed on slides, then deparaffinized in xylene for 5-10 min and subsequently rehydrated in PBS at pH 7.4 following the protocol previously described [19] . The sections were used for conventional histopathology using haematoxylin-eosin technique according to the Sydney System for the stomach (antrum) [28] and the presence of malgun cells (clear) as indicative of alterations induced by H. pylori [29] . Criteria similar to the Sydney System were applied to characterize patterns of inflammation in the oesophagus. The presence of the following features in the biopsies was determined: basal hyperplasia, metaplasia, plasma cells, lymphocyte, mononuclear cells and neutrophil infiltration and microabscesses [30] , as described previously [19] .
Immunofluorescence
Samples of gastric and oesophageal biopsies were fixed in PBS containing 4 % (w/v) paraformaldehyde at 4 C for 6 h. Sections 4-5 µm in thickness were cut and placed onto glass slides. Sections were dehydrated with ethanol, clarified with xylene and embedded in Paraplast (Sigma-Aldrich) [15] . After incubation steps, the slides were washed three times with PBS and incubated for 1 h at room temperature with goat polyclonal secondary antibodies: FITC-labelled anti-rabbit IgG (ab6717; Abcam) and anti-mouse IgG labelled with 5-TRICT (ab6897; Abcam), both diluted 1 : 500 in 0.1 % (w/v) PBS-T with 3 % (w/v) BSA. After the antibody reactions, the slides were washed with PBS and the nuclei, further stained with 4¢,6-diamidino-2-phenylindole (Molecular Probes, Life Technologies; 1 µg ml À1 for 10 min) and later washed with PBS. A negative control was incubated with blocking buffer (Fig. 1b) . These results indicate that the distribution of cag-PAI genotype profiles changes dramatically depending on the epithelium, suggesting that H. pylori strains can adapt to different microenviromental conditions leading to greater genetic diversity.
When we examined the distribution of the cag genotype profiles in the gastroesophageal mucosa in individual hosts (Fig. 2) , we found one patient carrying a single genotype with the same genetic composition of cag-PAI in both mucosae (patient 7). The other seven patients carried mixed genotypes with different cag-PAI composition in the antrum and oesophagus. Mixed and unique profiles were found in both mucosae from the same individual host. patients with different cag-PAI compositions, four had mixed genotypes in the stomach and single genotype in the oesophagus (patients 1, 2, 4 and 8), two patients had single genotype in the stomach and mixed genotypes in the oesophagus (patients 3 and 5) and only one patient had mixed genotypes in both mucosae (patient 6), suggesting that the isolates found in the oesophagus could come from circulating strains in the stomach, through recombination with colony variants of the same strain.
Antibiotic susceptibility and resistance test
Etest analysis from single colonies can evidence the phenotypic variability of H. pylori isolates in individual hosts ( Table 2 ). The rates of susceptibility for the 48 isolates from the gastric mucosa of eight patients were 100 % for clarithromycin, 100 % for amoxicillin, 60 % for levofloxacin, 77 % for tetracycline and 23 % for metronidazole, while susceptibility for the 48 isolates from the oesophagus was 98, 100, 81, 83 and 21 %, respectively.
We found six resistance profiles classified according to the combination of antibiotic resistance by isolate ( Table 2) . The most resistant profile in isolates from the gastric mucosa was Profile 1, found in 6 % (3/48 isolates), which showed resistance to levofloxacin, tetracycline and metronidazole. On the other hand, the most common profile was Profile 4 found in 42 % (20/48 isolates), showing resistance only to metronidazole. Profile 2 was observed in 13 % (6/48 isolates) and Profile 3 was observed in 17 % (8/48 isolates) showing resistance to levofloxacin and metronidazole or tetracycline and metronidazole. Profile 6 (2 %) showed susceptibility to all antibiotics (no resistance) in only one of 48 isolates. A similar pattern was observed in isolates from the oesophagus with the addition of a seventh profile where susceptibility to all antibiotics tested was found in seven of the 48 isolates ( Table 2 ). The phenotypic variability of H. pylori isolates on this study indicates that one patient can be coinfected with multiple H. pylori strains (single and/or mixed genotypes) in both mucosae at the same time ( Table 2) . The H. pylori variability in individual hosts may be associated with the recurrence of infection and antibiotic resistance.
Histopathology of the gastroesophageal mucosa
Histopathological analysis of the antrum gastric mucosa was performed in six of the eight dyspeptic patients (in two patients, the amount of the tissue was insufficient) and classified according to the Sydney System. Fig. 3 shows the histopathological alterations identified and their frequencies both in the gastric and oesophageal mucosa. In the antrum biopsy samples, all patients had chronic gastritis with dysplasia accompanied with monocyte and neutrophil infiltration and bacteria as the most frequent alterations (range from 66 to 100 %), whereas in oesophageal biopsies (7/8 patients), bacteria, microabscesses and neutrophil infiltration were the most common alterations (range from 40 to 57 %), suggesting a cellular immune response. Other changes such as hyperplasia, plasmocytes, dysplasia and metaplasia were also observed (Fig. 3) . The mean frequency of all alterations in the antral biopsies was significantly higher than that of the oesophageal biopsies (66.63±9.39 versus 34.71±6.88, P<0.05). These results may suggest that the high frequency of histopathological damages in the gastric mucosa is related to a higher proportion of complete cag-PAI in the antrum isolates.
Expression of CagA and IL-8 in the gastroesophageal mucosa
Immunofluorescence was performed on eight gastric and eight oesophageal biopsies, evaluating 10 fields per biopsy using epifluorescence microscopy for statistical analysis (total of 160 images). Additionally, six images per biopsy were obtained by confocal microscopy (laser scanning confocal microscopy) with immunofluorescence staining for CagA and IL-8 in the gastroesophageal mucosa (Fig. 4) . CagA expression was observed in the H. pylori cells (red dye) invading the mucosa and submucosa between the gastric cells [ Fig. 4a , b, differential interference contrast (DIC) images, white arrows] and in the submucosa of oesophagus (Fig. 4e, f) . Expression of IL-8 (green dye) was observed in the cytoplasm of the gastric and oesophageal cells (Fig. 4c, g ), showing higher expression of IL-8 in the stomach (Fig. 4d , white arrows) than in the oesophagus (Fig. 4h, white arrows) . (Fig. 5) . The difference in expression in the stomach and the oesophagus was statistically significant for both CagA (P<8.00eÀ14) and IL-8 (P<5.66eÀ8) (Fig. 5) . The association analysis between CagA and IL-8 showed a significant correlation value of 0.641 (P<1.45eÀ10) in the stomach, while it did not reach significant values in the oesophagus (0.118; P<0.294). These findings suggest that CagA induces higher IL-8 expression in the stomach than in the oesophagus.
DISCUSSION
The present study demonstrates the colonization with multiple H. pylori isolates in the oesophagus, like those found in the stomach, but with different cag-PAI genotypes in individual hosts in a Venezuelan population. Comparative analysis of the cag-PAI genotypes showed variations in the profiles obtained from colonies in the gastroesophageal mucosa. The genetic distribution of cag genotypes in the oesophagus displayed a large proportion of partial islands (62.50 % of isolates) in relationship to complete cag-PAI island (37.50 %), whereas in the stomach, complete cag-PAI island was detected in 77.08 %, and partial island in 22.92 % of isolates. The complete and partial island values in the stomach are in accordance with previous reports of singlecolony isolates and gastric biopsies from dyspeptic patients in a range from 58 to 90 % for a complete genotype and 4 to 85 % for a partial genotype [4, 10, 19, [31] [32] [33] . The variability observed evidences the heterogeneity of H. pylori through diverse genetic profiles with dominance of partial cag-PAI genotype in the oesophagus and complete cag-PAI in the stomach.
The frequency of the cagA gene in antrum isolates was higher (93.7±3.5 %), together with virB11 (98.8±2.9 %) and cagE (95.8±2.9 %), which correlated with severe histopathological alterations found in the gastric biopsies. In the oesophagus isolates, by contrast, we found a lower frequency of cagA (41.7±7.2 %) and similar frequencies for cagE (83.3±5.5 %) and virB11 (93.7±3.5 %). This suggests that cagA is the gene that establishes the difference between a complete and a partial cag-PAI profile in the presence of the other two genes, which, in turn, results in less virulent strains associated with less severe inflammation in the oesophageal mucosa as evidenced in the histopathological outcomes of this study.
The variability between H. pylori isolates was also observed when the cag genotype profiles in both mucosae were analysed in individual hosts. Samples from only one patient showed a single common genotype in both mucosae (patient 7, Fig. 2 ), whereas the other seven patients displayed mixed and/or single genotypes in both mucosae. This may suggest that strains in the oesophagus could originate from circulating strains in the stomach, through frequent genetic exchange as well as co-evolution of this bacterium to colonize different niches in the host. Our results demonstrate the genetic diversity of H. pylori in a single individual host with multiple strains of H. pylori in each mucosa. Each mucosa, antral or oesophageal, is dominated by a specific cag genotype, suggesting that adaptive host-induced changes occur during H. pylori infection. The existence of multiple H. pylori strains in the stomach with different genetic polymorphisms in an individual host has been demonstrated in numerous studies. Some authors correlate complete cag-PAI with severe clinical diseases associated with gastric and peptic ulcers, atrophic gastritis and gastric cancer [4, 5, 10, 12, 19, [32] [33] [34] and partial cag-PAI or deleted island with lower pathological damages in the gastric mucosa [31, 35] .
The phenotypic variability of H. pylori was also tested in antibiotic susceptibility and resistance assays using five antibiotics. These five antibiotics are the most recommended by international consensus (Maastrischt IV) to be used in triple or quadruple therapy for eradication of H. pylori infection. Our tests showed 100 % sensitivity to clarithromycin and amoxicillin in isolates from antrum and oesophagus (98 % sensitivity for clarithromycin and 100 % for amoxicillin). These results agree with previous studies in stomach isolates, which pointed out that prevalence of resistance varied from 0 to 38 % for amoxicillin and from 2 to 63 % (mean 14 % in 11 countries) for clarithromycin in Latin America [36] . In Venezuela, one study reported 7 % resistance [37] . Low percentage of resistance in our study may be attributed to low previous utilization of this antibiotic for the treatment of other infections or variability in resistance rates in different geographical areas of the same country, as previously reported [38] . [22, [40] [41] [42] [43] [44] [45] [46] . Global difference in resistance may be related to over-the-counter purchase of drugs, the use of substandard drugs and the consumption rate of these antibiotics. Fluoroquinolone resistance is easily acquired by inhibition of DNA gyrase, through point mutations in the quinolone resistance-determining region of the gyrA and gyrB genes, and topoisomerase [46, 47] . Additionally, fluoroquinolones may induce overexpression of multidrug efflux pumps as resistance mechanisms present in H. pylori [48] . These mechanisms could be acting in parallel to increase the resistance of this bacterium to the antibiotic. In this study, isolates from both mucosae also showed a high rate of resistance to levofloxacin, which may be associated with the increased use of this antibiotic in clinical practice.
Tetracycline resistance in oesophagus and antrum was 17 and 23 %, respectively. This phenotypic variability differs among isolates in both mucosae. Other studies report that tetracycline resistance is very low or even absent worldwide [22, 44] . Some cases of low resistance have been reported in Spain (0.7 %), United Kingdom (0.5 %) and Hong Kong (0.5 %), while higher rates were reported in Korea (5.3 %) and in some developing and emerging countries such as Brazil (9.0 %), Bangladesh (15 %) and Chile (27 %) [22, 49] . Tetracycline resistance, like other antibiotics, increases with the use of the drug due to selective pressure. We found high resistance similar to that reported in some developing and emerging countries and even higher than in another report in Venezuela where the rate of tetracycline resistance was 7 % in isolated strains from gastric biopsies between 1998 and 1999 [37] . This difference in resistance could be due to increased use of this antibiotic in past years in the Venezuelan population.
Resistance to metronidazole was rather high in both antrum (77 %) and oesophagus (79 %), agreeing with results of other studies in Venezuela (67 %) [37] . Although this antibiotic is recommended by international consensus, high resistance has been reported worldwide [45, 49, 50] . The prevalence of H. pylori resistance to metronidazole varies from Europe to America, Asia and Africa. It is known that its prevalence is highest in developing countries (50-80 %), such as Mexico (76 %) [51] and Venezuela (this study; [37] ), while it is lowest, around 17 %, in European countries [22, 44, 50, 52] . When other factors that influence the resistances were analysed, the use of metronidazole to treat parasitic infections in developing countries and nitroimidazoles for gynecological or dental infections in developed countries were the most prominent [49] . This is probably a risk factor for H. pylori resistance to metronidazole in patients with infections other than this bacterium. Other studies have shown that H. pylori is able to multiply within infected epithelial cells. This may explain the treatment failure in some cases and suggest that the difficulty in eradication of the disease is not caused only by the recurrence of antibiotic-resistant mutants [53] . Moreover, the coccid form of H. pylori on the plasma membrane (latent) is resistant to antibiotics and can spread to infect other cells in the absence of effective antibiotic concentration. Therefore, the antibiotic concentration must be high and prolonged in time, not only for eliminating H. pylori extracellularly but also for penetrating into epithelial cells to eliminate intracellular H. pylori [53] . Additionally, proton pump inhibitors must accompany therapy regimens against H. pylori due to the fact that the efficacy of some antibiotics is diminished at low pH. Therefore, proton pump inhibitors are used with antibiotics in the eradication of H. pylori with higher cure rates than without them [54] .
The H. pylori resistance profiles in both mucosae presented resistance from one to three antibiotics in 47 stomach isolates and 41 oesophagus isolates. This is the first study showing colonization of H. pylori from single colonies in the oesophageal mucosa. The diversity of resistance profiles allows us to confirm colonization by multiple strains of H. pylori of both inter-and intra-individual mucosa, which is also driven by the genetic variability of the cag genotypes found in single-colony isolates of H. pylori. The detection of strains with multiple resistance in individual hosts from Venezuela must be carried out to establish an effective treatment regimen. Clarithromycin and amoxicillin were the most effective antibiotics in this study, and they must be used with a proton pump inhibitor as first line therapy for the eradication of H. pylori infection.
When we evaluated the relationship between the integrity of the cag island and histopathological alterations, antral chronic gastritis was the most representative alteration accompanied by neutrophil and monocyte infiltration and bacteria. This indicates that cagA-positive island is able to induce an increased inflammatory response and mucosal damage. Assays carried out in vitro with three human gastric cancer cell lines have shown that CagA-positive H. pylori induces significantly more IL-8 secretion than CagA-negative strains [55] . Furthermore, CagA-positive H. pylori can also induce the secretion of IL-8 by oesophageal squamous carcinoma cells in vitro [56] . In this study, immunohistochemical detection of CagA showed marked expression, accompanied by increased induction of IL-8. There was a significant correlation between both expression in the antrum, together with histopathological changes of the gastric mucosa associated with inflammatory processes.
CagA and IL-8 expression in the oesophageal biopsies was low with minor histopathological and inflammatory alterations, suggesting that there are fewer strains expressing CagA in the oesophagus and therefore less IL-8 is induced. This result might indicate that IL-8 secretion differs among H. pylori strains (complete or partial cag-PAI) and is dependent on the host epithelial cells. The association analysis between CagA and IL-8 in the gastric mucosa was marked, significant with dominance of a complete cag-PAI, while the association in the oesophagus was mild, nonsignificant, but with dominance of a partial cag island. Perhaps cagA-negative strains are more likely to colonize the oesophagus than cagA-positive strains. Presumably, cagA-positive strains that induce a high inflammatory response are likely to be eradicated. To confirm these results, new studies using quantitative methods are necessary for determination of IL-8 expression induced by CagA-positive H. pylori in gastric and oesophageal cell lines stimulated with gastric and oesophageal H. pylori isolates and to examine whether there are substantial differences among epithelia.
Finally, the results both of cag genotypes and antibiotic resistance profiles demonstrate multiple H. pylori isolate colonization in the oesophageal mucosa. H. pylori in the oesophagus was characterized by a dominant partial island, low IL-8 induction with low histopathological alterations and low antibiotic resistance, whereas a complete cag-PAI, high induction of IL-8 with greater histopathological damage, and higher antibiotic resistance was found in the stomach antral mucosa. These results challenge the contention of the relationship between H. pylori infection and oesophageal disease and, therefore, make more studies necessary to understand the relationship between the H. pylori colonization and gastroesophageal reflux disease, Barrett's oesophagus and oesophageal adenocarcinoma. 
